This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2025
Title: Kevin Merchant: Innovator in Pharmaceutical Chemistry
Introduction
Kevin Merchant is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work primarily focuses on the development of innovative compounds that have therapeutic applications.
Latest Patents
Among his latest patents is the invention of Pyridazinone compounds and their use as DAAO inhibitors. This invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R and R' are defined in the specification. The patent also details processes for their preparation, pharmaceutical compositions containing them, and their use in therapy.
Career Highlights
Kevin Merchant is currently employed at Takeda Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His expertise in pharmaceutical chemistry has positioned him as a key player in the industry.
Collaborations
Throughout his career, Kevin has collaborated with notable colleagues, including William John Farnaby and Natasha Kinsella. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Kevin Merchant's innovative work in pharmaceutical chemistry exemplifies the impact of dedicated research and collaboration in the field. His contributions continue to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile